Sterling Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$855K Buy
4,387
+371
+9% +$76.9K 0.01% 608
2026
Q1
$902K Sell
4,016
-2,855
-42% -$711K 0.02% 539
2025
Q4
$1.66M Sell
6,871
-89
-1% -$22.8K 0.03% 461
2025
Q3
$1.91M Sell
6,960
-664
-9% -$181K 0.03% 411
2025
Q2
$1.97M Buy
7,624
+1,597
+26% +$381K 0.03% 399
2025
Q1
$1.35M Sell
6,027
-896
-13% -$209K 0.02% 499
2024
Q4
$1.58M Buy
6,923
+2,150
+45% +$518K 0.02% 492
2024
Q3
$1.17M Buy
+4,773
New +$1.07M 0.02% 541

Other funds holding RMD

Sterling Capital Management's RMD Position: Q2 2026 in Review

Sterling Capital Management increased its ResMed (RMD) stake by 9.2% in Q2 2026, buying an estimated $76.9K and bringing the position to 4,387 shares worth $855K. The position accounts for 0.01% of the portfolio, ranked #608.

Sterling Capital Management first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.97M in Q2 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Sterling Capital Management held 4,387 shares of ResMed worth $855K as of Q2 2026.
  • Sterling Capital Management bought 371 ResMed shares in Q2 2026, an estimated $76.9K.
  • ResMed made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #608 holding.
  • Sterling Capital Management first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's ResMed position peaked at $1.97M in Q2 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.